{"AllianceGenome": "4177", "HGNC": "4177", "MIM": "606463", "_id": "2629", "_version": 1, "accession": {"genomic": ["AC217785.3", "AF023268.1", "AH006907.2", "AL713999.28", "CH471121.2", "CP068277.2", "KX710179.1", "M18916.1", "M18917.1", "M20248.1", "M20282.1", "NC_000001.11", "NC_060925.1", "NG_009783.1", "NW_003315906.1", "S44217.1", "S44219.1"], "protein": ["AAA35873.1", "AAA35874.1", "AAA35875.1", "AAA35876.1", "AAA35877.1", "AAA35878.1", "AAA35879.1", "AAA35880.1", "AAC51820.1", "AAC63056.1", "AAH03356.1", "AID60277.1", "AID60278.1", "AID60279.1", "ASU47376.1", "BAA02545.1", "BAF84600.1", "BAG35404.1", "BAH12898.1", "BAH13232.1", "BAH13357.1", "BAH13365.1", "BAH13467.1", "BAH13574.1", "BAH13605.1", "BBC83066.1", "BBC83067.1", "BBC83068.1", "EAW53100.1", "EAW53101.1", "EAW53102.1", "EAW53103.1", "NP_000148.2", "NP_001005741.1", "NP_001005742.1", "NP_001165282.1", "NP_001165283.1", "P04062.3"], "rna": ["AK291911.1", "AK298900.1", "AK300186.1", "AK300829.1", "AK300876.1", "AK301374.1", "AK301879.1", "AK302000.1", "AK311242.1", "AK312502.1", "AL547558.3", "AU122729.1", "AU131071.1", "AU140959.1", "AU141794.1", "BC003356.1", "BI458641.1", "BX382279.2", "BX477204.1", "BX648487.1", "D13286.1", "DC297079.1", "K02920.1", "KJ690771.1", "KJ690772.1", "KJ690773.1", "LC050340.1", "LC050341.1", "LC050342.1", "M16328.1", "M19285.1", "NM_000157.4", "NM_001005741.3", "NM_001005742.3", "NM_001005749.1", "NM_001005750.1", "NM_001171811.2", "NM_001171812.2"], "translation": [{"protein": "BAA02545.1", "rna": "D13286.1"}, {"protein": "AID60278.1", "rna": "KJ690772.1"}, {"protein": "BBC83066.1", "rna": "LC050340.1"}, {"protein": "AAH03356.1", "rna": "BC003356.1"}, {"protein": "BAH13574.1", "rna": "AK301879.1"}, {"protein": "NP_000148.2", "rna": "NM_000157.4"}, {"protein": "NP_001005742.1", "rna": "NM_001005742.3"}, {"protein": "NP_001165283.1", "rna": "NM_001171812.2"}, {"protein": "BBC83068.1", "rna": "LC050342.1"}, {"protein": "BAF84600.1", "rna": "AK291911.1"}, {"protein": "AAA35880.1", "rna": "M19285.1"}, {"protein": "BAG35404.1", "rna": "AK312502.1"}, {"protein": "AID60277.1", "rna": "KJ690771.1"}, {"protein": "BAH13467.1", "rna": "AK301374.1"}, {"protein": "BBC83067.1", "rna": "LC050341.1"}, {"protein": "AAA35873.1", "rna": "M16328.1"}, {"protein": "BAH13232.1", "rna": "AK300186.1"}, {"protein": "BAH13605.1", "rna": "AK302000.1"}, {"protein": "BAH12898.1", "rna": "AK298900.1"}, {"protein": "BAH13357.1", "rna": "AK300829.1"}, {"protein": "BAH13365.1", "rna": "AK300876.1"}, {"protein": "NP_001005741.1", "rna": "NM_001005741.3"}, {"protein": "NP_001165282.1", "rna": "NM_001171811.2"}, {"protein": "AAA35877.1", "rna": "K02920.1"}, {"protein": "AID60279.1", "rna": "KJ690773.1"}]}, "alias": ["GBA", "GCB", "GLUC"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": [{"classification": "definitive", "classification_date": "2022-05-03T13:48:10.206Z", "disease_label": "Parkinson disease", "gcep": "Parkinson's Disease Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0005180", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9201c03f-10de-447c-9b84-194f14b549b6-2022-05-03T134810.206Z", "sop": "SOP8"}, {"classification": "definitive", "classification_date": "2020-06-24T16:00:00.000Z", "disease_label": "Gaucher disease", "gcep": "General Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0018150", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbc5a876-f97e-4f9c-be99-664e2f6c8470-2020-06-24T160000.000Z", "sop": "SOP10"}]}, "ec": ["3.2.1.45", "3.2.1.46"], "ensembl": [{"gene": "ENSG00000262446", "protein": ["ENSP00000458274", "ENSP00000459642", "ENSP00000482397", "ENSP00000482419"], "transcript": ["ENST00000570340", "ENST00000570491", "ENST00000570868", "ENST00000571863", "ENST00000571897", "ENST00000572338", "ENST00000573492", "ENST00000573812", "ENST00000573998", "ENST00000574670", "ENST00000574935", "ENST00000575321", "ENST00000576421", "ENST00000576759", "ENST00000613861", "ENST00000618489"], "translation": [{"protein": "ENSP00000459642", "rna": "ENST00000572338"}, {"protein": "ENSP00000458274", "rna": "ENST00000574670"}, {"protein": "ENSP00000482397", "rna": "ENST00000613861"}, {"protein": "ENSP00000482419", "rna": "ENST00000618489"}], "type_of_gene": "protein_coding"}, {"gene": "ENSG00000177628", "protein": ["ENSP00000314508", "ENSP00000357357", "ENSP00000397986", "ENSP00000402577"], "transcript": ["ENST00000327247", "ENST00000368373", "ENST00000427500", "ENST00000428024", "ENST00000460156", "ENST00000464536", "ENST00000467918", "ENST00000470104", "ENST00000473570", "ENST00000478472", "ENST00000484489", "ENST00000491081", "ENST00000493842", "ENST00000497670"], "translation": [{"protein": "ENSP00000357357", "rna": "ENST00000368373"}, {"protein": "ENSP00000314508", "rna": "ENST00000327247"}, {"protein": "ENSP00000402577", "rna": "ENST00000427500"}, {"protein": "ENSP00000397986", "rna": "ENST00000428024"}], "type_of_gene": "protein_coding"}], "entrezgene": "2629", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 18.7876451011, "exp_mis": 180.636456438, "exp_syn": 76.262851766, "lof_z": 2.92242984562477, "mis_z": 2.06115219160816, "mu_lof": 1.38954345972e-06, "mu_mis": 1.69260190094e-05, "mu_syn": 6.86244202908e-06, "n_lof": 6.0, "n_mis": 124.0, "n_syn": 75.0, "p_li": 0.0340405400496017, "p_null": 0.00172674195536255, "p_rec": 0.964232717995036, "syn_z": 0.0896488564969013}, "bp": 1611, "cds_end": 155210903, "cds_start": 155204785, "n_exons": 11, "nonpsych": {"exp_lof": 16.7940905199, "exp_mis": 163.282887529, "exp_syn": 68.8147043713, "lof_z": 2.82642960417054, "mis_z": 2.22160988579629, "mu_lof": 1.38954345972e-06, "mu_mis": 1.69260190094e-05, "mu_syn": 6.86244202908e-06, "n_lof": 5.0, "n_mis": 107.0, "n_syn": 69.0, "p_li": 0.0905437825827647, "p_null": 0.00220214885546089, "p_rec": 0.907254068561774, "syn_z": -0.0140636587843216}, "nontcga": {"exp_lof": 17.2641118758, "exp_mis": 166.165029659, "exp_syn": 70.1413100503, "lof_z": 2.91169072140049, "mis_z": 2.01613419159709, "mu_lof": 1.38954345972e-06, "mu_mis": 1.69260190094e-05, "mu_syn": 6.86244202908e-06, "n_lof": 5.0, "n_mis": 114.0, "n_syn": 71.0, "p_li": 0.0974837009435035, "p_null": 0.00159345559136574, "p_rec": 0.900922843465131, "syn_z": -0.0649189955054315}, "transcript": "ENST00000327247.5"}, "exons": [{"cdsend": 46135, "cdsstart": 40017, "chr": "1_GL383519v1_alt", "position": [[39474, 40123], [40217, 40334], [40703, 40867], [41267, 41492], [42363, 42601], [43156, 43329], [43539, 43673], [44638, 44785], [44908, 45100], [45652, 45740], [46108, 46272]], "strand": -1, "transcript": "NM_000157", "txend": 46272, "txstart": 39474}, {"cdsend": 155241112, "cdsstart": 155234994, "chr": "1", "position": [[155234451, 155235100], [155235194, 155235311], [155235680, 155235844], [155236244, 155236469], [155237340, 155237578], [155238133, 155238306], [155238516, 155238650], [155239615, 155239762], [155239885, 155240077], [155240629, 155240717], [155241085, 155241249]], "strand": -1, "transcript": "NM_000157", "txend": 155241249, "txstart": 155234451}, {"cdsend": 3290, "cdsstart": 0, "chr": "1_GL383519v1_alt", "position": [[0, 201], [797, 1004], [1006, 1037], [1272, 1445], [1655, 1789], [2120, 2262], [2379, 2492], [2492, 2536], [2538, 2563], [2803, 2895], [3263, 3426]], "strand": -1, "transcript": "NM_000157", "txend": 3426, "txstart": 0}, {"cdsend": 46135, "cdsstart": 40017, "chr": "1_GL383519v1_alt", "position": [[39474, 40123], [40217, 40334], [40703, 40867], [41267, 41492], [42363, 42601], [43156, 43329], [43539, 43673], [44638, 44785], [44908, 45100], [45652, 45740], [46108, 46203], [49528, 49650]], "strand": -1, "transcript": "NM_001005741", "txend": 49650, "txstart": 39474}, {"cdsend": 155241112, "cdsstart": 155234994, "chr": "1", "position": [[155234451, 155235100], [155235194, 155235311], [155235680, 155235844], [155236244, 155236469], [155237340, 155237578], [155238133, 155238306], [155238516, 155238650], [155239615, 155239762], [155239885, 155240077], [155240629, 155240717], [155241085, 155241180], [155244505, 155244627]], "strand": -1, "transcript": "NM_001005741", "txend": 155244627, "txstart": 155234451}, {"cdsend": 3290, "cdsstart": 0, "chr": "1_GL383519v1_alt", "position": [[0, 201], [797, 1004], [1006, 1037], [1272, 1445], [1655, 1789], [2120, 2262], [2379, 2492], [2492, 2536], [2538, 2563], [2803, 2895], [3263, 3358]], "strand": -1, "transcript": "NM_001005741", "txend": 3358, "txstart": 0}, {"cdsend": 46135, "cdsstart": 40017, "chr": "1_GL383519v1_alt", "position": [[39474, 40123], [40217, 40334], [40703, 40867], [41267, 41492], [42363, 42601], [43156, 43329], [43539, 43673], [44638, 44785], [44908, 45100], [45652, 45740], [46108, 46184], [49528, 49650]], "strand": -1, "transcript": "NM_001005742", "txend": 49650, "txstart": 39474}, {"cdsend": 3290, "cdsstart": 0, "chr": "1_GL383519v1_alt", "position": [[0, 201], [797, 1004], [1006, 1037], [1272, 1445], [1655, 1789], [2120, 2262], [2379, 2492], [2492, 2536], [2538, 2563], [2803, 2895], [3263, 3339]], "strand": -1, "transcript": "NM_001005742", "txend": 3339, "txstart": 0}, {"cdsend": 155241112, "cdsstart": 155234994, "chr": "1", "position": [[155234451, 155235100], [155235194, 155235311], [155235680, 155235844], [155236244, 155236469], [155237340, 155237578], [155238133, 155238306], [155238516, 155238650], [155239615, 155239762], [155239885, 155240077], [155240629, 155240717], [155241085, 155241161], [155244505, 155244627]], "strand": -1, "transcript": "NM_001005742", "txend": 155244627, "txstart": 155234451}, {"cdsend": 44954, "cdsstart": 40017, "chr": "1_GL383519v1_alt", "position": [[39474, 40123], [40217, 40334], [40703, 40867], [41267, 41492], [42363, 42601], [43156, 43329], [43539, 43673], [44638, 44785], [44908, 45100], [49528, 49650]], "strand": -1, "transcript": "NM_001171811", "txend": 49650, "txstart": 39474}, {"cdsend": 2424, "cdsstart": 0, "chr": "1_GL383519v1_alt", "position": [[0, 201], [797, 1004], [1006, 1037], [1272, 1445], [1655, 1789], [2120, 2262], [2379, 2561]], "strand": -1, "transcript": "NM_001171811", "txend": 2561, "txstart": 0}, {"cdsend": 155239931, "cdsstart": 155234994, "chr": "1", "position": [[155234451, 155235100], [155235194, 155235311], [155235680, 155235844], [155236244, 155236469], [155237340, 155237578], [155238133, 155238306], [155238516, 155238650], [155239615, 155239762], [155239885, 155240077], [155244505, 155244627]], "strand": -1, "transcript": "NM_001171811", "txend": 155244627, "txstart": 155234451}, {"cdsend": 155241112, "cdsstart": 155234994, "chr": "1", "position": [[155234451, 155235100], [155235194, 155235311], [155235680, 155235844], [155236244, 155236469], [155237340, 155237578], [155238133, 155238306], [155238516, 155238650], [155239885, 155240077], [155240629, 155240717], [155241085, 155241249]], "strand": -1, "transcript": "NM_001171812", "txend": 155241249, "txstart": 155234451}, {"cdsend": 3290, "cdsstart": 0, "chr": "1_GL383519v1_alt", "position": [[0, 201], [797, 1004], [1006, 1037], [1272, 1445], [1655, 1789], [2379, 2492], [2492, 2536], [2538, 2563], [2803, 2895], [3263, 3426]], "strand": -1, "transcript": "NM_001171812", "txend": 3426, "txstart": 0}, {"cdsend": 46135, "cdsstart": 40017, "chr": "1_GL383519v1_alt", "position": [[39474, 40123], [40217, 40334], [40703, 40867], [41267, 41492], [42363, 42601], [43156, 43329], [43539, 43673], [44908, 45100], [45652, 45740], [46108, 46272]], "strand": -1, "transcript": "NM_001171812", "txend": 46272, "txstart": 39474}], "exons_hg19": [{"cdsend": 155210903, "cdsstart": 155204785, "chr": "1", "position": [[155204242, 155204891], [155204985, 155205102], [155205471, 155205635], [155206035, 155206260], [155207131, 155207369], [155207924, 155208097], [155208307, 155208441], [155209406, 155209553], [155209676, 155209868], [155210420, 155210508], [155210876, 155211040]], "strand": -1, "transcript": "NM_000157", "txend": 155211040, "txstart": 155204242}, {"cdsend": 155210903, "cdsstart": 155204785, "chr": "1", "position": [[155204242, 155204891], [155204985, 155205102], [155205471, 155205635], [155206035, 155206260], [155207131, 155207369], [155207924, 155208097], [155208307, 155208441], [155209406, 155209553], [155209676, 155209868], [155210420, 155210508], [155210876, 155210971], [155214296, 155214418]], "strand": -1, "transcript": "NM_001005741", "txend": 155214418, "txstart": 155204242}, {"cdsend": 155210903, "cdsstart": 155204785, "chr": "1", "position": [[155204242, 155204891], [155204985, 155205102], [155205471, 155205635], [155206035, 155206260], [155207131, 155207369], [155207924, 155208097], [155208307, 155208441], [155209406, 155209553], [155209676, 155209868], [155210420, 155210508], [155210876, 155210952], [155214296, 155214418]], "strand": -1, "transcript": "NM_001005742", "txend": 155214418, "txstart": 155204242}, {"cdsend": 155209722, "cdsstart": 155204785, "chr": "1", "position": [[155204242, 155204891], [155204985, 155205102], [155205471, 155205635], [155206035, 155206260], [155207131, 155207369], [155207924, 155208097], [155208307, 155208441], [155209406, 155209553], [155209676, 155209868], [155214296, 155214418]], "strand": -1, "transcript": "NM_001171811", "txend": 155214418, "txstart": 155204242}, {"cdsend": 155210903, "cdsstart": 155204785, "chr": "1", "position": [[155204242, 155204891], [155204985, 155205102], [155205471, 155205635], [155206035, 155206260], [155207131, 155207369], [155207924, 155208097], [155208307, 155208441], [155209676, 155209868], [155210420, 155210508], [155210876, 155211040]], "strand": -1, "transcript": "NM_001171812", "txend": 155211040, "txstart": 155204242}], "generif": [{"pubmed": 11584048, "text": "simple non-isotopic method to show pitfalls during mutation analysis of the glucocerebrosidase gene"}, {"pubmed": 11708865, "text": "A protocol is described for the isolation of genomic DNA from formalin-fixed bone marrow aspirate archival specimens."}, {"pubmed": 11933202, "text": "seven novel missense mutations in the glucocerebrosidase gene (A136E, H162P, K198E, Y205C, F251L, Q350X and I402F) and a splice site mutation (IVS10+2T-->A) were identified by direct sequencing"}, {"pubmed": 12048121, "text": "In conclusion, 12% of Hypoalphalipoproteinemia subjects were found to carry mutations in apo A-I, LCAT, or GBA genes"}, {"pubmed": 12107439, "text": "PKLR- GBA region shows almost complete linkage disequilibrium over 70 kb in a set of worldwide populations."}, {"pubmed": 12173027, "text": "incidence of the most common mutations and phenotypic manifestations in Romanian Gaucher disease patients"}, {"pubmed": 12359135, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12360742, "text": "Review. Beta-glucosidase deficiency causes autosomal recessive Gaucher disease. Cloning of the gene has allowed the characterization of few common mutations. Some have a prognostic value, favoring either a non neurological form or more severe forms."}, {"pubmed": 12360744, "text": "Review. 2-dimensional hydrophobic cluster analysis was used to make structure predictions for the catalytic domains of clan GH-A glycoside hydrolases. Glu 235 & Glu 340 do indeed play key roles in the active site of human glucocerebrosidase as predicted."}, {"pubmed": 12434014, "text": "N-n-nonyl-deoxynojirimycin chaperones beta-Glu folding at neutral pH, thus allowing the stabilized enzyme to transit from the endoplasmic reticulum to the Golgi, enabling proper trafficking to the lysosome."}, {"pubmed": 12482401, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12587096, "text": "Reciprocal and nonreciprocal recombination at this region implies complexity in Gaucher disease."}, {"pubmed": 12667141, "text": "substrate specificity of the cytosolic enzyme"}, {"pubmed": 12792654, "text": "X-ray structure of acid-beta-glucosidase at 2.0 A resolution"}, {"pubmed": 12803123, "text": "report a 36-year-old Turkish man with type I Gaucher's disease with homozygous R463C mutation without neurological involvement"}, {"pubmed": 12972024, "text": "Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"}, {"pubmed": 14728994, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14757764, "text": "Glucosylceramidase mass and subcellular localization are modulated by cholesterol in Niemann-Pick disease type C"}, {"pubmed": 14994233, "text": "Mutations in Glucocerebrosidase is associated with Gaucher disease"}, {"pubmed": 15146461, "text": "a baculovirus-derived expression system to express cDNAs bearing several mutations found in Spanish Gaucher disease patients"}, {"pubmed": 15322500, "text": "Six of 16 haplotypes were found, and none was over- or underrepresented among patients with the severe Gaucher disease phenotypes compared with those from patients with mild phenotypes."}, {"pubmed": 15517591, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15517591, "text": "The N370S allele of glucosidase, beta (nt.1226 A>G) may be associated with Parkinson's disease in patients of Jewish ethnicity."}, {"pubmed": 15517592, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15517592, "text": "Our results demonstrate a marginally significant association of GBA mutations with Parkinson's disease and suggest that variations in the GBA gene may constitute a rare susceptibility factor for PD."}, {"pubmed": 15525722, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15525722, "text": "heterozygosity for a GBA mutation may predispose Ashkenazi Jews to Parkinson's disease"}, {"pubmed": 15591280, "text": "mutant glucocerebrosidase, even in heterozygotes, may be a risk factor for the development of parkinsonism"}, {"pubmed": 15610510, "text": "alteration in water permeability barrier in lesional psoriatic skin can serve as a trigger for the upregulation of the expression of enzymes like GlcCer'ase with consequent stimulation of ceramide generation."}, {"pubmed": 15857183, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15954102, "text": "Expression of novel GBA mutations revealed that the enzyme defect could arise from one of two mechanisms: loss of catalytic activity (Y363C and M416V) or enzyme instability (P122L and N382K)."}, {"pubmed": 15967693, "text": "The high frequency of the E326K substitution observed in patients with GD type 2 suggests that this change may have a modulating negative effect on the clinical condition of these Gaucher disease patients when present in combination with mutation L444P."}, {"pubmed": 15982918, "text": "Data describe the intracellular trafficking of glucocerebrosidase as an underlying mechanism for the expression of the clinical phenotype."}, {"pubmed": 16086325, "text": "the glucocerebrosidase Gaucher mutation N188S associated with myoclonic epilepsy"}, {"pubmed": 16148263, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16148263, "text": "The overall clinical manifestations and age at Parkinson disease onset of Ashkenazi Jews did not differ in patients with GBA mutations compared to patients without mutations."}, {"pubmed": 16329099, "text": "Two novel disease-causing splicing mutations in the glucocerebrosidase gene, g.4252C>G and g.4426A>G, that have been found in two patients affected by Gaucher disease."}, {"pubmed": 16476943, "text": "This study does not indicate increased susceptibility to Parkinson disease in glucocerebrosidase mutations carriers in Norway."}, {"pubmed": 16781064, "text": "Mutations in glucocerebrosidase are identified at an increased frequency among Parkinson probands, including those of Ashkenazi Jewish ancestry."}, {"pubmed": 16790605, "text": "Glucocerebrosidase mutations are an important risk factor for Lewy body disorders"}, {"pubmed": 16830265, "text": "the double D409H+H255Q allele may have a role in type II Gaucher disease within specific populations"}, {"pubmed": 16861620, "text": "Turning off hGCase expression led to storage cell reaccumulation of GC and macrophage activation in liver, lung, and spleen, demonstrating that conditionally expressed hGCase supplements mutant mouse GCase controlling visceral substrate accumulation"}, {"pubmed": 16981045, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16996765, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17187079, "text": "Isofagomine binds to the acid beta-glucosidase (GCase) active site, and both increases GCase activity in cell lysates and restores lysosomal trafficking in cells containing N370S mutant GCase."}, {"pubmed": 17427031, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17427031, "text": "identified 98.7% of mutated GBA alleles, finding 56 different mutations & 66 genotypes causing Gaucher disease in Spain: 47 previously described & 9 novel; findings indicate genotypic heterogeneity explaining phenotypic variation in Spanish GD patients"}, {"pubmed": 17462935, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17462935, "text": "study demonstrates that GBA mutations are also encountered in Chinese subjects with sporadic Parkinson disease (PD) at higher frequency than many other PD genes & association of GBA mutations with development of PD is not related to ethnic origin"}, {"pubmed": 17574891, "text": "report from Lebanon describes a family with Gaucher disease caused by a heterozygous genotype of a rare mutation, R48W, and a common one, L444P"}, {"pubmed": 17620502, "text": "The L444P mutation is associated with an increased risk of PD anmong the Chinese population."}, {"pubmed": 17689991, "text": "gene sequencing and mRNA analysis in four patients from three unrelated families with type 3 Gaucher disease"}, {"pubmed": 17702778, "text": "Mutations of the GBA gene may be associated with the development of EOPD in Taiwan."}, {"pubmed": 17702778, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17703984, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17703984, "text": "evidence for glucocerebrosidase gene mutations being a possible hereditary risk factor for PD."}, {"pubmed": 17713797, "text": "Clinical manifestation of Gaucer disease is driven by point mutation and the placement of S-binding sites."}, {"pubmed": 17875915, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17875915, "text": "This study suggests that the Glucocerebrosidase gene may be a susceptibility gene for Parkinson disease and that Glucocerebrosidase mutations may modify age at onset."}, {"pubmed": 17996473, "text": "Gaucher disease is an inherited recessive autosomal metabolic defect due to a deficiency of the lysosomal enzyme beta-glucocerebrosidase."}, {"pubmed": 18030725, "text": "Association of GBA gene mutation and Gaucher disease."}, {"pubmed": 18074383, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18074383, "text": "These results strongly suggest that Italian carriers of a GBA mutation have an increased risk of developing PD."}, {"pubmed": 18078074, "text": "126 mutation alleles from 136 investigated alleles were identified."}, {"pubmed": 18160183, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18160183, "text": "These results, together with recent literature, clearly suggest a role of glucocerebrosidase in the development of Parkinson disease."}, {"pubmed": 18178337, "text": "Asparagine 370 Serine mutation is responsible for Gaucher disease."}, {"pubmed": 18264947, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 18313951, "text": "first report of a Gaucher disease patient carrier of de novo mutation, without previous family history of this mutation"}, {"pubmed": 18332251, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18332251, "text": "We observed a significantly higher heterozygote frequency for the 2 mutations (N370S and L444P) in patients with PD and those with DLB."}, {"pubmed": 18338393, "text": "discuss the spectrum of glucocerebrosidase mutations and their distribution in the patient population, evolutionary conservation, clinical presentations, and how they may affect the structure and function of glucocerebrosidase"}, {"pubmed": 18429048, "text": "Using 5 microsatellite polymorphisms near the GBA gene, 37 chromosomes analysed showed that most of them share a common haplotype and are consistent with a single origin in the Balkans and the Adriatic area of Italy for the D409H;H255Q allele."}, {"pubmed": 18434642, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18434642, "text": "These data demonstrate genotype-phenotype correlations between different glucocerebrosidase mutations and Parkinson disease (PD) risk and age at PD onset in Ashkenazi Jews."}, {"pubmed": 18541113, "text": "Strong evidence for linkage was detected on the chromosome 2q35-q36 region (logarithm of odds score of 3.01). Therefore, this region might harbor a novel important gene for DLB."}, {"pubmed": 18562733, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18586535, "text": "GENOTYPE/PHENOTYPE RELATIONSHIPS IN GAUCHER DISEASE"}, {"pubmed": 18586596, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18619939, "text": "The low levels of human lysosomal glucocerebrosidase activity results from a cryptic splice site present in the wildtype Gcc complementary DNA."}, {"pubmed": 18674488, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18829375, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18852351, "text": "In the homozygous and heterozygous states, GBA mutations are associated with a spectrum of parkinsonian phenotypes ranging from Parkinson disease, mostly of the akinetic type, to a less common phenotype characteristic of Lewy body dementia."}, {"pubmed": 18979180, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18987351, "text": "GBA is a susceptibility gene for familial Parkinson disease (PD); patients with GBA variants have an earlier age at onset than patients with PD without GBA variants"}, {"pubmed": 18987351, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19224617, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19224617, "text": "This study found that no associations were seen for GBA in Australia patient with Parkinson's disease"}, {"pubmed": 19260119, "text": "Homozygous N370S GD leads to adult-onset progressive skeletal disease with relative sparing of the viscera, a strikingly high risk of multiple myeloma, and an increased risk of other cancers."}, {"pubmed": 19260119, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19286695, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19286695, "text": "This study demonstrates that GBA mutations are found in British subjects (on a non-Jewish patient sample)at a higher frequency than any other known Parkinson's disease gene."}, {"pubmed": 19332698, "text": "GBA mutations are not associated with multiple system atrophy (MSA)in 108 neuropathologically diagnosed cases of MSA; this branch of the ceramide pathway is unlikely to be associated with all types of primary (alpha)-synuclein deposition."}, {"pubmed": 19332698, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19383421, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19383421, "text": "Overall, GBA mutations were significantly overrepresented in a subgroup of early onset PD patients, compared to controls (P = 0.019, OR = 4.2; 95%CI = 1.28 -- 13.82), suggesting that GBA mutations may modify age of onset for PD."}, {"pubmed": 19394250, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19394250, "text": "Three novel Glucocerebrosidase variants were identified and assessed as being likely pathogenic mutations: c.413delC, W357C and D405V."}, {"pubmed": 19425057, "text": "There is an association between GBA mutations and the development of parkinsonism. GBA mutation is a PD risk factor across different centers, synucleinopathies, and ethnicities. Review."}, {"pubmed": 19433656, "text": "Heterozygous pathogenic variants in GBA confer a high risk for sporadic PD, even for familial clustering, and are associated with significantly earlier age at onset of disease."}, {"pubmed": 19433656, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19433657, "text": "GBA mutations may be associated with pathologically \"purer\" LB disorders, characterized by more extensive (cortical) LB, and less severe AD pathological findings and may be a useful marker for LB disorders."}, {"pubmed": 19433657, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19458969, "text": "LRRK2 or GBA mutations have roles in the initial presentation of Parkinson disease"}, {"pubmed": 19459886, "text": "Glucocerebrosidase mutation H255Q appears to be exclusively in cis with D409H: structural implications."}, {"pubmed": 19527940, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19527940, "text": "The GBA mutation is not associated with essential tremor."}, {"pubmed": 19578116, "text": "Upon binding of ambroxol, amino acid segments 243-249, 310-312, and 386-400 near the active site of glucocerebrosidase are stabilized."}, {"pubmed": 19846850, "text": "Data collected from 16 centers demonstrate that there is a strong association between GBA mutations and Parkinson's disease."}, {"pubmed": 19846850, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19882201, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19945510, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20004703, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20004703, "text": "data suggest that the GBA L444P mutation plays an important role in the development of Parkinson's disease also in Han-Chinese patients from Mainland China"}, {"pubmed": 20053430, "text": "Functional expression of hGCase in mammary gland cells and normal development to Day 40 of cloned embryos carrying the hGCase gene."}, {"pubmed": 20131388, "text": "The results of this study suggested that the GBA gene L444P mutation appears to be a risk factor for Parkinson's disease in Chinese population."}, {"pubmed": 20148966, "text": "isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase"}, {"pubmed": 20177787, "text": "patients with Gaucher disease 1 have an almost 20-fold increased life-time risk of developing Parkinson disease"}, {"pubmed": 20182943, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20182943, "text": "We compared Mini-Mental State Examination performance and self-reported cognitive impairment in early onset Parkinson diseaseparticipants genotyped for mutations in parkin, leucine-rich repeat kinase-2, and glucocerebrosidase"}, {"pubmed": 20223112, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20425034, "text": "To date, there are approximately 300 mutations and polymorphisms in the GBA gene that have been identified in patients with varying presentations of Gaucher disease, Parkinson disease and Lewy body disorders."}, {"pubmed": 20528910, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20580583, "text": "Reduction in imiglucerase dosage causes immediate rise of chitotriosidase activity in patients with Gaucher disease"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20700730, "text": "Apolipoprotein E, growth factor receptor-bound protein 2, Golgi SNAP receptor complex member 1, and glucosidase, beta, acid may play a neurodegenerative role in stress urinary incontinence development."}, {"pubmed": 20729108, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20816920, "text": "A strong association is found between glucoscerebrosidase gene mutations and an increased risk of early-onset Parkinson's disease in a Brazilian population."}, {"pubmed": 20816920, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20947659, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20971030, "text": "GBA mutations are associated with a more diffuse pattern of Lewy body distribution involving the cerebral cortex than the brainstem/limbic distribution observed in typical Parkinson's disease"}, {"pubmed": 20980259, "text": "Molecular basis of reduced glucosylceramidase activity in the most common Gaucher disease mutant, N370S"}, {"pubmed": 20980263, "text": "N370S mutation in acid beta-glucosidase results in a normally folded but less flexible protein with reduced catalytic activity compared with imiglucerase"}, {"pubmed": 21087600, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21087600, "text": "The c.(-203)A>G variant may produce a more severe phenotype in patients with Gaucher disease"}, {"pubmed": 21098288, "text": "Data suggest that specific molecular mediators involved in glucocerebrosidase maturation and degradation, and abnormal interaction with TCP1 and c-Cbl, could be responsible for phenotypic variation among patients with the same genotypes."}, {"pubmed": 21221911, "text": "In this article we review the GBA gene and its protein product, with associated defects, lipid metabolism and storage, enzyme misfolding and endoplasmic reticulum stress, calcium homeostasis, oxidative stress and autophagy."}, {"pubmed": 21242499, "text": "study found GBA mutations were more frequent in patients of North African origin with Parkinson disease than in ethnically matched control subjects"}, {"pubmed": 21338444, "text": "The Leu444Pro mutation in GBA may contribute to an earlier onset of development of Parkinson's disease in a Han/Chinese population."}, {"pubmed": 21569768, "text": "The kinetics of alpha-galactosidase A and beta-glucocerebrosidase deficient in Fabry and Gaucher diseases, respectively, is reported."}, {"pubmed": 21621439, "text": "Glucocerebrosidase mutations do not cause increased Lewy body pathology in Parkinson's disease"}, {"pubmed": 21633851, "text": "L444P is the most common allele and L444P/Rec alleles are the most common genotypes in Egyptian children.  There is no significant association between genotypes and phenotypes."}, {"pubmed": 21653695, "text": "the alpha-syn-GCase association is favored in the lysosome, and that this noncovalent interaction provides the groundwork to explore molecular mechanisms linking PD with mutant GBA alleles."}, {"pubmed": 21700325, "text": "These findings suggest that the bidirectional effect of alpha-syn and glucocerebrosidase forms a self-propagating feedback loop Gaucher disease."}, {"pubmed": 21723784, "text": "link between glucocerebrosidase mutations and parkinsonism [review]"}, {"pubmed": 21734182, "text": "Patients with GBA-PD more often had a variety of nonmotor symptoms, namely dementia, neuropsychiatric disturbances, and autonomic dysfunction, and had more severe cases, than patients with PD negative for GBA mutations."}, {"pubmed": 21742527, "text": "Patients with GBA1-associated synucleinopathies showed aggregation of oligomeric forms of alpha-synuclein in the SDS-soluble fraction, while only monomeric forms of alpha-synuclein were seen in subjects with GBA1 mutations without parkinsonism."}, {"pubmed": 21745757, "text": "GBA mutations were identified with increased frequency in both geographical cohorts of patients with sporadic Parkinson's disease studied compared to control individuals."}, {"pubmed": 21831682, "text": "Biochemical characterization of the E326K amino acid change (1093G>A in the GBA1 cDNA) in tissue culture and its association with Parkinson disease, are summarized."}, {"pubmed": 21856586, "text": "This study indicated that GBA variation contribute to development of Parkinson disease in French-Canadian."}, {"pubmed": 21889374, "text": "novel F331S mutation in the GBA gene in patients with Gaucher disease type 2"}, {"pubmed": 21915911, "text": "The study demonistrated that GBA L444P, N370S mutations are genetic susceptibility factors for Parkinson's disease in Russia."}, {"pubmed": 22001711, "text": "Sequence variations at the glucocerebrosidase gene may play a role as a minor, modifying gene of Machado Joseph/spinocerebellar ataxia 3 phenotype."}, {"pubmed": 22021190, "text": "This study demonistraed that abnormalities of fatty acid metabolism are specifically involved in the pathogenesis of Parkinson's disease associated with a heterozygous glucocerebrosidase mutation."}, {"pubmed": 22167193, "text": "IFG stabilizes GCase in tissues and serum and can reduce visceral substrates in vivo."}, {"pubmed": 22173904, "text": "The results of this study suggested that mutations in the glucocerebrosidase gene increase the risk of both Parkinson's disease and Lewy body dementia"}, {"pubmed": 22192918, "text": "This study demonistrated that Glucocerebrosidase N370S and L444P mutations as risk factors for Parkinson's disease in Brazilian patients."}, {"pubmed": 22220748, "text": "Based on estimates of the frequencies of N370S and L444P GBA mutatons in the general population of Spain, the number of patients with Gaucher disease that are homozygous for N370S and heterozygous for N370S/L444P were below the expected numbers."}, {"pubmed": 22227325, "text": "properties of E326K glucocerebrosidase alone and in combination with known Gaucher Disease mutations are presented"}, {"pubmed": 22282650, "text": "The relatively high penetrance estimate in GBA carriers with Parkinson Disease suggests that GBA should be considered a dominant causal gene with reduced penetrance."}, {"pubmed": 22344629, "text": "This study providenced evidence that GD patients and heterozygote GBA mutation carriers exhibit certain features consistent with the PD clinical prodrome."}, {"pubmed": 22352271, "text": "lung disease in children homoallelic for L444P mutation in GBA gene is a significant clinical manifestation of GD with unclear response to ERT."}, {"pubmed": 22387070, "text": "Our results suggest that heterozygous mutations of GBA represent a risk factor for Parkinson disease in Koreans."}, {"pubmed": 22427207, "text": "Heterozygous mutations in the gene encoding the lysosomal enzyme beta-glucocerebrosidase (GBA) are associated with an increased susceptibility to Parkinson's disease."}, {"pubmed": 22442429, "text": "GBA mutation status may be an independent risk factor for cognitive impairment in patients with PD."}, {"pubmed": 22493294, "text": "Discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis."}, {"pubmed": 22542428, "text": "The genotype GBA-N370S/RecNciI was most frequent in patients with Gaucher disease childhood onset and it was associated with severe visceral involvement."}, {"pubmed": 22658918, "text": "The GBA1 gene was sequenced as part of a molecular characterization of 73 adult patients in the United Kingdom."}, {"pubmed": 22659419, "text": "GBA1 and GBA2 activities had characteristic differences between the studied fibroblast, liver and brain samples."}, {"pubmed": 22803570, "text": "Glucocerebrosidase mutations alter the endoplasmic reticulum and lysosomes in brain cells of patients with Lewy body disease."}, {"pubmed": 22812582, "text": "Glucocerebrosidase mutations represent a PD risk factor in the Serbian population."}, {"pubmed": 22935721, "text": "Data indicate age-specific estimates of Parkinson disease penetrance in patients with Gaucher disease and beta-glucocerebrosidase (GBA) carriers for genetic counseling."}, {"pubmed": 22968580, "text": "GBA1 heterozygotes with non-N370S mutations associated with Gaucher disease have an increased risk of parkinsonism compared to those with N370S mutations."}, {"pubmed": 23034917, "text": "This studiws confirm a widespread deficiency of GCase activity in the brains of parkinson disease patients carrying GBA mutations"}, {"pubmed": 23035075, "text": "GBA is a susceptibility gene across the Lewy body disease spectrum, but not in Alzheimer disease , and appears to convey a higher risk for parkinson disease and Lewy body disease than for Lewy body disease -Alzheimer disease ."}, {"pubmed": 23062841, "text": "Both transcranial sonography and positron emission tomography are abnormal in glucocerebrosidase mutation associated Parkinson disease, similar to other Parkinson disease subjects"}, {"pubmed": 23079555, "text": "[review] Identification of the pathological mechanisms underlying GBA-associated parkinsonism will improve our understanding of the genetics, pathophysiology, and treatment for both rare and common neurological diseases."}, {"pubmed": 23151436, "text": "There is no significant association of GBA gene Leu444Pro mutation and disease in a sample of essential tremor and multiple system atrophy patients from mainland China."}, {"pubmed": 23225227, "text": "the most prevalent Parkinson's disease-associated GBA1 mutation is E326K"}, {"pubmed": 23227814, "text": "Our observations demonstrated that the GBA L444P mutation confers genetic risk for Parkinson disease, especially late oneset Parkinson disease, among the population in the central China area."}, {"pubmed": 23255161, "text": "ITCH interacts with mutant GCase variants and mediates their lysine 48 polyubiquitination and degradation."}, {"pubmed": 23286447, "text": "results suggests that the GBA gene may be a susceptibility gene for Parkinson's disease in the Chinese population (meta-analysis)"}, {"pubmed": 23413260, "text": "Genetic variation in GBA has an important impact on the natural history of Parkinson's disease."}, {"pubmed": 23418083, "text": "No white matter abnormalities were found in Parkinson's disease patients without glucocerebrosidase gene mutations."}, {"pubmed": 23426826, "text": "a novel L385R missense mutation that is associated with type 1 Gaucher disease (GD)."}, {"pubmed": 23434032, "text": "FKBP10 depletion enhances glucocerebrosidase proteostasis in Gaucher disease fibroblasts"}, {"pubmed": 23448517, "text": "The L444P GBA mutation is associated with early-onset Parkinson's disease in Mexican Mestizos."}, {"pubmed": 23490118, "text": "from the genetic point of view we can exclude that GBA mutations are a major cause of multiple system atrophy"}, {"pubmed": 23580063, "text": "Loss of beta-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells."}, {"pubmed": 23588557, "text": "Mutations in GBA1 are a significant risk factor for dementia with Lewy bodies."}, {"pubmed": 23635853, "text": "Our patient had an unusual mutation responsible for his GD. Although corneal opacities are virtually unknown in gaucher disease, except in the D409H homozygous cardiovascular subtype, this patient had marked corneal stromal abnormalities."}, {"pubmed": 23639447, "text": "Retinal thinning in Gaucher disease patients and heterozygous GBA mutation carriers who manifest clinical markers of potential early neurodegeneration."}, {"pubmed": 23676350, "text": "meta-analysis provides evidence that both mutations are risk factors associated with increased PD susceptibility."}, {"pubmed": 23699752, "text": "Patients having Parkinson's disease with GBA mutations have earlier age at disease onset and are more likely to demonstrate cognitive dysfunction."}, {"pubmed": 23719189, "text": "Two novel mutations, a missense (c.1204T>C, p.Y402H), and a termination codon mutation (c.1609T>C, p.X537A)in GBA gene were found. The p.X537A mutation decreased the amount of protein and the enzymatic activity, while it correctly localizes."}, {"pubmed": 23811968, "text": "This study demonustrated that GBA mutation related to Parkinson's disease in Gaucher disease."}, {"pubmed": 23812893, "text": "Although the specific contribution of mutant GBA to the pathogenesis of parkinsonism remains unknown, evidence suggests that both loss of function and toxic gain of function by abnormal ss-glucocerebrosidase may be important."}, {"pubmed": 23936319, "text": "Mutations in GBA is associated with neurodevelopmental defects and ER stress in Drosophila eye."}, {"pubmed": 24022302, "text": "identification and functional characterization of 11 novel GBA mutations in Gaucher disease patients"}, {"pubmed": 24070323, "text": "Saposin C protects glucocerebrosidase against alpha-synuclein inhibition."}, {"pubmed": 24095219, "text": "mutations in the GBA gene represent a genetic risk factor for sporadic Parkinson disease."}, {"pubmed": 24126159, "text": "Heterozygous GBA mutations are strong risk factors in FPD, especially for autosomal dominant Parkinson disease."}, {"pubmed": 24219755, "text": "GBA mutations represent a major genetic risk factor for the development of Parkinson disease (PD); GBA-PD is clinically, pharmacologically, and pathologically virtually indistinguishable from sporadic PD [review]"}, {"pubmed": 24243800, "text": "GBA mutation status may be significantly associated with Parkinson's disease (Meta-Analysis)"}, {"pubmed": 24262184, "text": "The lysosomal enzyme coding genes GBA which are associated with a 5-fold increased risk of Parkinson disease."}, {"pubmed": 24351928, "text": "glucocerebrosidase activity is increased after administration of celastrol in Gaucher disease cells by modulating molecular chaperones"}, {"pubmed": 24434810, "text": "study describes 2 novel mutations in 2 Type 1 Gaucher patients with N370S compound heterozygosity; a point mutation that causes an amino acid substitution at cysteine residue 23 for tryptophan, and a second point mutation within the splicing element at the 3' end of intron 7"}, {"pubmed": 24477431, "text": "Glucocerebrosidase deficits in sporadic Parkinson's disease are related to the abnormal accumulation of alpha-synuclein and are associated with substantial alterations in lysosomal chaperone-mediated autophagy pathways and lipid metabolism."}, {"pubmed": 24522292, "text": "L444P is the most common mutant allele with exons 8 and 10 as the hot spot region of GBA gene observed in Indian GD patients."}, {"pubmed": 24531622, "text": "There is now a well-established clinical association between mutations in the glucocerebrosidase gene and the development of more prevalent multifactorial disorders including Parkinson's disease and other synucleinopathies"}, {"pubmed": 24574503, "text": "Glucocerebrosidase mutations are associated with reductions in glucosylceramidase activity and evidence of oxidative stress."}, {"pubmed": 24577513, "text": "The novel heterozygous mutations c.798C>G and c.1040T>G. in a consanguineous Iranian family were associated with 2 fatal untreated cases and 1 severe case successfully treated with enzyme replacement."}, {"pubmed": 24756352, "text": "Patients with Gaucher disease and glucocerebrosidase heterozygotes have an increased age-specific risk for Parkinson disease compared with control individuals"}, {"pubmed": 24905578, "text": "findings provide evidence for a link between GBA1 mutations and complex changes in the autophagic/lysosomal system and intracellular calcium homeostasis, which underlie vulnerability to neurodegeneration"}, {"pubmed": 24919969, "text": "Different short-term memory deficit patterns are associated with GBA mutation and with Parkinson's disease."}, {"pubmed": 24997549, "text": "GBA mutations are an important risk of Parkinson's disease in the Thai population."}, {"pubmed": 25084554, "text": "G202R mutation in glucocerebrosidases causes Gaucher disease."}, {"pubmed": 25156829, "text": "GBA1 depletion enhances cell-to-cell transmission of alpha-synuclein, conforming GBA1 role in alpha-syneclein transmission."}, {"pubmed": 25168325, "text": "The N370S GBA mutation is the risk factor for cognitive impairment in Parkinson disease patients."}, {"pubmed": 25202012, "text": "The LIMP-2/SCARB2 binding sequences for enterovirus 71 and GCase are not similar, indicating that LIMP-2/SCARB2 may have multiple or overlapping binding sites with differing specificities."}, {"pubmed": 25249066, "text": "This study demonstrated that Glucocerebrosidase mutations in primary parkinsonism."}, {"pubmed": 25429104, "text": "We propose a model of a-syn.GCase on the membrane, providing structural insights into inhibition of GCase by a-syn"}, {"pubmed": 25448271, "text": "This study show that GBA-associated PD patients compared with non-mutation PD patients present with (1) more rapid disease progression of motor impairment and cognitive decline and (2) reduced survival rates."}, {"pubmed": 25506732, "text": "GBA mutation-positive individuals show a deterioration in clinical markers consistent with the prodrome of Parkinson."}, {"pubmed": 25518742, "text": "Data indicate that the frequency of glucocerebrosidase gene (GBA) mutations within Chinese Parkinson's disease (PD) cohort was 8.7%, which is significantly higher than 1.54% observed in the control cohort."}, {"pubmed": 25535748, "text": "The present study used a meta-analysis approach, pooling the appropriate data from published studies to investigate the association of GBA mutations and Parkinson's disease in a Chinese population."}, {"pubmed": 25552189, "text": "Ceramide, the product of hydrolysis of glucosylceramide by GBA and involved in the regulation of cell differentiation, survival and apoptosis, is another putative candidate linking increased GBA activity to preeclampsia."}, {"pubmed": 25583479, "text": "the Hsp90/HOP/Cdc37 complex recruits Hsp27 after recognition of GCase mutants with subsequent targeting of GCase mutant peptides to degradation mechanisms such as VCP and the 26S proteasome."}, {"pubmed": 25600808, "text": "Binding of C-terminal residues of Saposin C stabilizes glucocerebrosidase monomer. Dimer dissociation by Saposin C likely due to binding near enzymatic active site."}, {"pubmed": 25653295, "text": "mild and severe heterozygous GBA mutations differentially affect the risk and age at onset of Parkinson disease (Meta-Analysis)"}, {"pubmed": 25813221, "text": "Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and alpha-synuclein aggregation."}, {"pubmed": 25914293, "text": "Data indicated that GBA and TMEM175/GAK significantly alter age at onset in PD."}, {"pubmed": 25946768, "text": "Five novel mutations causing Gaucher disease reported. Slovak patients show a profile characteristic of European population, with the N370S, L444P and RecNciI mutations being the most prevalent."}, {"pubmed": 25952961, "text": "A pattern of combined segregation with GBA and LRRK2 was found in a Brazilian family with Parkinson's disease."}, {"pubmed": 26000814, "text": "GBA mutations were found to be a common genetic risk factor for Parkinson disease in Eastern Canadian patients."}, {"pubmed": 26018676, "text": "Although hrGCase cellular uptake is independent of LIMP-2, its trafficking to the lysosomes is mediated by this receptor."}, {"pubmed": 26096906, "text": "This study did not demonstrate glucocerebrosidase substrate accumulation in Parkinson's disease brains with heterozygote GBA1 mutations in areas of the brain with low alpha-synuclein pathology."}, {"pubmed": 26117366, "text": "The association of lower glucocerebrosidase activity in both GBA mutation carriers and Parkinson's patients without GBA mutations suggests that loss of glucocerebrosidase function contributes to the pathogenesis of Parkinson's disease."}, {"pubmed": 26214314, "text": "The most highly correlated pair of residue variations is alpha-synuclein A53T and glucocerebrosidase G115E. Intriguingly, the A53T mutation is a Parkinson's disease risk factor in humans, suggesting the pathology associated with this mutation"}, {"pubmed": 26220978, "text": "GBA1 mutations interfere with TFEB-mediated lysosomal biogenesis, and that the action of GBA in maintaining a functioning pool of lysosomes is exerted in part through TFEB."}, {"pubmed": 26268663, "text": "This study showed the presence of six LRRK2 p.G2019S and nine GBA p.N370S mutation carriers in Parkinson disease."}, {"pubmed": 26296077, "text": "This study discovery that E326K of GBA negatively impacts cognitive performance approximately doubles the proportion of PD patients"}, {"pubmed": 26422360, "text": "findings showed that Gaucher disease (GD)-associated GBA mutations were not only associated with the development of Parkinson's disease (PD) but also had a great impact on developing dementia and psychosis in the clinical course of PD"}, {"pubmed": 26547032, "text": "the most frequent L444P mutation of the GBA gene may be associated with the development of early-onset Parkinson disease in the Hungarian population."}, {"pubmed": 26549049, "text": "The clinical phenotype of GBA-associated neurodegenerative disease is more heterogeneous than previously assumed, including phenotypes not usually associated with underlying alpha-synucleinopathies."}, {"pubmed": 26589705, "text": "In this study, we produced hGCase through the direct injection of recombinant adenovirus in the mammary gland of a non-transgenic goat"}, {"pubmed": 26601739, "text": "Its genetic variation influences Parkinson disease risk, age of onset, and progression."}, {"pubmed": 26743617, "text": "there has been a boom in studies investigating the role of glucocerebrosidase in the pathology of Parkinson's disease. This merits a comprehensive review of the current cell biological processes and pathological pictures involving Parkinson's disease associated with GBA mutations"}, {"pubmed": 26849828, "text": "Combination of chemo drug with beta-glucosidase 1 inhibitor sensitized hepatocellular carcinoma (HCC) cells to chemotherapy.  Our data support b-glucosidase 1 as a HCC biomarker due to its prognosis significance"}, {"pubmed": 26857292, "text": "GBA enzyme activity in Parkinson disease patients was lower in GBA mutation carriers vs. non-GBA carriers."}, {"pubmed": 26860875, "text": "the GBA1 gene, its role in Gaucher disease, and its link with Parkinson disease (Review)"}, {"pubmed": 26868973, "text": "the study supported that GBA mutations were a risk factor for Parkinson's disease in the European population"}, {"pubmed": 26965692, "text": "Mutant GBA proteins cause increases in alpha-synuclein levels, while an inhibition of GBA by alpha-synuclein has been also demonstrated in Gaucher disease patients with Parkinson disease. (Review)"}, {"pubmed": 27019408, "text": "Our findings indicate that dGBA1b plays an important role in the metabolism of protein aggregates, but that the deleterious consequences of mutations in dGBA1b are largely independent of a-synuclein"}, {"pubmed": 27027900, "text": "GBA mutations are also an important risk factor for DLB development in the Spanish population, are associated with earlier disease onset, and are more prevalent in men."}, {"pubmed": 27085534, "text": "identified the significant associations of the GBA L444P mutation and DYRK1A rs8126696 T allele with the earlier age at onset (AAO) in Parkinson's disease (PD) patients, and the A allele at MS4A6A rs610932 with the delayed AAO of PD."}, {"pubmed": 27238910, "text": "Enzyme activities (acid alpha-glucosidase (GAA), galactocerebrosidase (GALC), glucocerebrosidase (GBA), alpha-galactosidase A (GLA), alpha-iduronidase (IDUA) and sphingomyeline phosphodiesterase-1 (SMPD-1)) were measured on ~43,000 de-identified dried blood spot (DBS) punches, and screen positive samples were submitted for DNA sequencing to obtain genotype confirmation of disease risk"}, {"pubmed": 27255555, "text": "GBA mutations as risk factors for PD and point to lysosomal dysfunction as a mechanism contributing to PD etiology."}, {"pubmed": 27269966, "text": "This study shown GBA genetic variants for Parkinson's disease are associated with the risk of incident Parkinson's disease in the general population and with impairment in daily functioning in individuals without clinical parkinsonism."}, {"pubmed": 27378698, "text": "Rab7 accumulated in GCase deficient cells, supporting the notion that lysosomal recycling is impaired.  Since recombinant GCase can reverse ALR impairment, we anticipate that strategies to restore GCase activity in the brains of both sporadic patients with PD and those with GBA1 mutations will improve autophagy lysosomal pathway, preventing the accumulation of a-synuclein and spread of pathology."}, {"pubmed": 27397011, "text": "In a Flanders-Belgian cohort, carrier status of a heterozygous glucocerebrosidase (GBA) mutation was a strong genetic risk factor for Parkinson's disease (PD). The GBA mutation frequency of 4.5% is comparable to previously reported data in other European PD patient cohorts."}, {"pubmed": 27401793, "text": "Parkinson patient who carry mutations in the GBA gene demonstrates more significant cognitive decline compared to idiopathic parkinson patients."}, {"pubmed": 27449028, "text": "Parkinson's disease is associated with mutations in GBA. Ashkenazi Jews GBA carriers were singled at a significantly earlier age at diagnosis compared to noncarriers."}, {"pubmed": 27571329, "text": "GBA variants predict a more rapid progression of cognitive dysfunction and motor symptoms in patients with Parkinson's."}, {"pubmed": 27632223, "text": "In the clinical continuum between PD and DLB, patients with GBA mutations seem to localize midway, with carriers of severe mutations closer to DLB than to idiopathic PD."}, {"pubmed": 27717005, "text": "Mutations in the GBA gene pathogenic for neuropathic GD and complex alleles shift longitudinal cognitive decline in PD into \"high gear.\""}, {"pubmed": 27723861, "text": "Mutations in the GBA gene were associated with more severe motor and cognitive dysfunction, supporting a specific contribution of the GBA gene or lysosome function in Lewy body disease among Ashkenazi Jews."}, {"pubmed": 27745782, "text": "This study showed that GBA L444P and SNCA Rep-1 were also associated with depression in Parkinson's disease."}, {"pubmed": 27772789, "text": "Results suggest that GBA1 mutations confer greater risk of neuropsychiatric morbidity in Parkinson disease, and that sex may affect this association"}, {"pubmed": 27777137, "text": "the important contribution of GBA (L444P and N370S) mutations to parkinsonism in Brazilian families."}, {"pubmed": 27780739, "text": "the decrease in enzymatic activity of lysosomal hydrolases in GBA mutation carriers may contribute to Parkinson disease pathogenesis by increasing the level of neurotoxic oligomeric alpha-synuclein species."}, {"pubmed": 27802905, "text": "These results demonstrate the diagnostic usefulness of MLPA in the detection of GBA deletions and recombinations"}, {"pubmed": 27825739, "text": "The aims in the present study were to validate the P338-X1 GBA kit (MRC-Holland) for Multiplex Ligation-dependent Probe Amplification (MLPA) and to detect large deletions and/or duplications in GBA1 in Gaucher disease (GD) patients from Southern Brazil. Although larger deletions/duplications do not appear to be frequent in GD, the P338-X1 GBA kit for MLPA appears to be a good method for GBA1 analysis."}, {"pubmed": 27856178, "text": "These results indicated activation of Unfolded Protein Response (UPR) in different cell types derived from Gaucher disease patients, highlighting the generality of this process in this disease. They also showed that the UPR-regulated CHOP transcription factor induces transcription of the GBA1 gene."}, {"pubmed": 27864021, "text": "This study found that 10/13 Parkinson's disease parents had a severe mutation and only 3/10 carried a mild mutation (binomial test P < 0.05). Using an unbiased methodology, this study showed that carriers of severe GBA mutations are at higher risk for Parkinson's disease relative to carriers of the mild mutations."}, {"pubmed": 27865684, "text": "The mutation spectrum of GBA exhibits ethnic and regional disparity in Asian patients. L444P was the most frequent mutation accounted for 47.7% in southern Chinese patients. The L444P homozygote genotype was associated with severe type 1 Gaucher disease."}, {"pubmed": 28003644, "text": "Although a common ancestry among Southern Italian and Swedish Norrbottnian GD patients could not be investigated, the beta glucosidase genotype [L444P]+[L444P] is the most frequently encountered in Southern Italy"}, {"pubmed": 28012950, "text": "dose effect of mutations in the GBA gene on Parkinson's disease phenotype; severity of Parkinson's disease phenotype is related to the burden of GBA mutations with Gaucher disease-Parkinson's disease patients manifesting a more severe phenotype"}, {"pubmed": 28030538, "text": "course of motor and non-motor symptoms as well as treatment-related motor complications could be influenced by GBA variants"}, {"pubmed": 28098348, "text": "Mesenchymal stem cells with reduced GBA activity are prone to apoptosis and senescence due to impaired autophagy and DNA repair capacity."}, {"pubmed": 28126847, "text": "Local lysosomal conditions may be even more critical for some mutant lysosomal hydrolases, e.g. for mutant GBA1 . In Niemann-Pick disease type C disease, characterized by the cholesterol primary storage, GlcCer secondary accumulation could be triggered by SM secondary accumulation."}, {"pubmed": 28141506, "text": "The anti-enterovirus 71 activity of GBA1 was bimodal: endogenous GBA1 restricted cell surface expression levels of scavenger receptor class B, member 2 (SCARB2), also known as lysosomal integral membrane protein 2 (LIMP-2), and exogenous recombinant GBA1 interfered with enterovirus 71 to interact with SCARB2 outside the cell."}, {"pubmed": 28356566, "text": "Low Glucosylceramidase serum levels are associated with Gaucher disease."}, {"pubmed": 28574511, "text": "these findings highlight the critical role of GBA1 in mediating enhanced self-consumption of intracellular components and endomembranes, leading to autophagic cell death."}, {"pubmed": 28596107, "text": "A novel function for glucocerebrosidase as a regulator of sterylglucoside metabolism has been summarized. (Review)"}, {"pubmed": 28598007, "text": "This study investigated 22 unrelated Chinese patients, including their clinical presentations, plasma psychosine levels and beta-galactocerebrosidase gene mutations. We found the late-onset form of Krabbe disease (KD) present in 82% of the patients in our study, which was more prevalent than in patients from other populations."}, {"pubmed": 28728889, "text": "examined the effect of heterozygous mutation status on 736 community-dwelling older adults without dementia or Parkinson's disease over an average of 6 years, 28 of whom had a single GBA mutation (primarily N370S); carriers showed greater decline in verbal memory over time;results suggest an effect, but an overall limited burden, of harboring a single GBA mutation in aging mutation carriers"}, {"pubmed": 28777757, "text": "This study demonstrated that GBA status appears to be an important predictor for non-motor symptom disease progression, after deep brain stimulation surgery."}, {"pubmed": 28779532, "text": "The results of this study support a connection between the loss of beta-glucocerebrosidase-1 function, cholesterol accumulation, and the disruption of cellular homeostasis in GBA1-PD."}, {"pubmed": 28830825, "text": "that GBA variant E326K may fully account for the primary association signal observed at chromosome 1q22 in previous GWAS of PD"}, {"pubmed": 28834018, "text": "In longitudinally assessed, autopsied Parkinson disease cases, those with GBA mutations had a younger age at death but there was no evidence for clinical or neuropathological differences compared to cases without GBA mutations."}, {"pubmed": 28894968, "text": "This study showed that Lysosomal defects GBA associated familial Parkinson's disease."}, {"pubmed": 28983119, "text": "Using skin-derived induced pluripotent stem cells of PD patients with GBA mutations and controls, we observed a significant GBA up-regulation during dopaminergic differentiation, paralleled by down-regulation of miR-22-3p. Our results describe the first microRNA controlling GBA and suggest that the GBAP1 non-coding RNA functions as a GBA ceRNA"}, {"pubmed": 28991672, "text": "comparative analysis of motor and non-motor features in LRRK2 and GBA mutation carriers and non-carriers conducted in a cohort from Brazil, a country with a highly miscegenated population. Similarly to other studies, our results suggest that mutations in GBA and LRRK2 influence the clinical signs of the Parkinson's disease, with significant implications for handling of specific patient groups."}, {"pubmed": 29029963, "text": "The POLG1 CAG repeat length variation and the GBA p.L444P variant are associated with Parkinson's disease in the Finnish population"}, {"pubmed": 29094781, "text": "The data of this study suggested that the prominent cognitive impairment in Glucocerebrosidase (GBA)-associated Parkinson disease seems not primarily associated with specific Abeta and Tau profiles in CSF."}, {"pubmed": 29100779, "text": "Loss of GBA activity is associated with Gaucher Disease."}, {"pubmed": 29311330, "text": "lipid dyshomeostasis by GBA1 deficiency leads to decreased alpha-synuclein tetramers and increased alpha-synuclein monomers, which may provide the building blocks for phospho-Ser129-positive aggregates in GBA1-Parkinson's disease induced pluripotent stem cell-derived dopaminergic neurons"}, {"pubmed": 29378790, "text": "Study confirms the influence of glucocerebrosidase mutations on the age of onset, disease severity and motor phenotype in patients with Parkinson's disease."}, {"pubmed": 29530815, "text": "The p.L216I mutation is a novel glucocerebrosidase (GBA)mutation, which we identified in two Han Chinese patients with Parkinson disease. The patients exhibited similar characteristics, which differed from those seen in patients with other GBA mutations."}, {"pubmed": 29579237, "text": "We demonstrated that deficiency of GCase(GBA1) leads to a reduction of C18-ceramide species and altered intracellular localization of Rab8a, a small GTPase implicated in secretory autophagy, that contributed to impaired secretion of a-synuclein and accumulation of intracellular a-synuclein."}, {"pubmed": 29784561, "text": "This study showed that Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene."}, {"pubmed": 29792872, "text": "A total of 12.0% of patients with Parkinson's disease carried a GBA variant, and nearly half (22/53) of them progressed to dementia during follow-up. Carriers of deleterious GBA mutations or polymorphisms progressed to dementia more rapidly than noncarriers."}, {"pubmed": 29920646, "text": "The p.Trp378Gly mutation is the first French-Canadian founder GBA mutation to be described, which leads to synucleinopathies and to GD type 1 when in compound heterozygosity with p.Asn370Ser"}, {"pubmed": 29934114, "text": "Chinese type 2 Gaucher disease patients have a similar phenotype to other ethnic groups and have a high prevalence of the c.1448T>C (p.Leu483Pro) mutation and recombination alleles."}, {"pubmed": 29980418, "text": "we identified patients found to carry more than one GBA1 mutation on the same allele. It is essential to examine the entire GBA1 gene in order to establish an accurate genotype. Missing the second mutation can complicate genotype/phenotype studies and result in improper genetic counseling"}, {"pubmed": 30160596, "text": "The Parkinson disease-associated L444P Gba/GBA mutation impairs mitochondrial function by inhibiting mitophagy."}, {"pubmed": 30192031, "text": "This study demonstrated that the Lysosphingolipid accumulations in parkinson's disease patients who bear glucocerebrosidase 1 mutations suggest that substrate reduction therapy might be viewed as a possible strategy for glucocerebrosidase 1-parkinson's disease treatment"}, {"pubmed": 30285649, "text": "The study reports novel and known variants identified in the GBA gene in seven adult Indian patients with Gaucher disease."}, {"pubmed": 30288804, "text": "This study demonstrated that Survival of patients with Parkinson's disease does not seem to be related to GBA status."}, {"pubmed": 30337601, "text": "In recently diagnosed Parkinson's disease patients, GCase activity was significantly reduced in monocytes, but not lymphocytes, compared to controls, even when GBA1 mutation carriers were excluded. Monocyte GCase activity correlated with plasma ceramide levels in the Parkinson's disease patients."}, {"pubmed": 30340368, "text": "The binding affinities of a-1-C-alkyl 1,4-dideoxy-1,4-imino-d-arabinitol (DAB) derivatives, which act as pharmacological chaperones for beta-glucocerebrosidase, abruptly increased upon elongation of their alkyl chain. In this study, the primary causes of such an increase in binding affinity were analyzed using proteinligand docking and molecular dynamics simulations."}, {"pubmed": 30504558, "text": "GBA mutation may not be so common in Indian patients with Parkinson disease as compared to the other ethnic populations."}, {"pubmed": 30528172, "text": "When Parkinson's disease affected family members with GBA mutations were compared with clinically unaffected carrier family members, there was a poor correlation between the development of PD and the expression level of GBA or GCase activity"}, {"pubmed": 30573413, "text": "GBA-Parkinson's disease patients have higher rates of dementia compared to LRRK2-Parkinson's disease patients."}, {"pubmed": 30615125, "text": "Co-expression of human a-synuclein and human mutant GCase in the dopaminergic cells of flies initiated a-synuclein aggregation, earlier death of these cells and significantly shorter life span, compared with flies expressing a-synuclein or mutant GCase alone."}, {"pubmed": 30640255, "text": "our findings show that the pattern of verbal fluency deficits in patients with DLB who carry one of the 7 AJ GBA mutations is different from the pattern commonly found in AD, whereas patients with DLB who do not carry GBA mutations show a pattern of verbal fluency deficits typical of AD."}, {"pubmed": 30764785, "text": "Study reports four novel and 29 known mutations identified in the GBA1 gene in one-hundred Gaucher patients. The given study establishes p.Leu483Pro as the most prevalent mutation in the Indian patients with type 1 Gaucher disease."}, {"pubmed": 30765263, "text": "GBA mutations are strongly associated with PD risk and earlier age at onset in Peru and Colombia."}, {"pubmed": 31065058, "text": "GBA and APOE epsilon4 associate with sporadic dementia with Lewy bodies in European genome wide association study."}, {"pubmed": 31076265, "text": "GBA mutations may accelerate the conversion of RBD to defined neurodegenerative synucleinopathy."}, {"pubmed": 31189032, "text": "pathogenic GBA1 mutations seem to be associated with CSF alpha-synuclein profiles in dementia with Lewy bodies"}, {"pubmed": 31221723, "text": "In this 6-year-long longitudinal study, GBA1 mutation-positive subjects showed a worsening in motor and non-motor prodromal Parkinson disease features, including REM-sleep behavior disorder, hyposmia, cognitive dysfunction, depression, and autonomic dysfunction."}, {"pubmed": 31251436, "text": "As a result of the low conversion rate in our glucocerebrosidase mutation carriers to date, prospective validation is needed in larger cohorts to establish the profile of these features in Parkinson disease convertors"}, {"pubmed": 31291241, "text": "PGRN interacts with the lysosomal enzyme, glucocerebrosidase (GCase), and is essential for proper GCase activity. This is further evidence that reduced lysosomal hydrolase activity may be a pathological mechanism in cases of GRN-related frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis."}, {"pubmed": 31292011, "text": "Systematic review of genetic variants associated with cognitive impairment and depressive symptoms in Parkinson's disease."}, {"pubmed": 31672490, "text": "Effects of glucocerebrosidase gene polymorphisms and mutations on the risk of Parkinson's disease dementia: A meta-analysis."}, {"pubmed": 31680121, "text": "Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists."}, {"pubmed": 31751314, "text": "GBA mutation promotes early mitochondrial dysfunction in 3D neurosphere models."}, {"pubmed": 31755958, "text": "Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia."}, {"pubmed": 31761523, "text": "GBA1 mutations: Prospects for exosomal biomarkers in alpha-synuclein pathologies."}, {"pubmed": 31804465, "text": "Results suggest an important role of mutant leucine rich repeat kinase 2 (LRRK2) as a negative regulator of lysosomal glucocerebrosidase (GCase) activity."}, {"pubmed": 31809948, "text": "Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson's disease cohort."}, {"pubmed": 31813991, "text": "LRRK2 and GBA Variants Exert Distinct Influences on Parkinson's Disease-Specific Metabolic Networks."}, {"pubmed": 31899072, "text": "Reduced GCase activity does not result in aggregation of alpha-synuclein. However, in the context of extant misfolded alpha-synuclein, GCase activity modulates neuronal susceptibility to pathology. Furthermore, this modulation does not depend on neuron type but rather is driven by the level of pathological alpha-synuclein seeds."}, {"pubmed": 31912918, "text": "Decreased Penetrance of Parkinson's Disease in Elderly Carriers of Glucocerebrosidase Gene L444P/R Mutations: A Community-Based 10-Year Longitudinal Study."}, {"pubmed": 31931749, "text": "The diagnosis of GD is performed by measurement of the GCase activity in leukocytes and fibroblasts of individuals with clinical suspicion of the disease. Analysis of the GBA1 gene is also performed to identify the genotype of the patients. The standard method for variant analysis in GD is full-gene sequencing of GBA1."}, {"pubmed": 31978134, "text": "GBA mutation is associated with Gait asymmetry in Parkinson's disease."}, {"pubmed": 32073681, "text": "Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study."}, {"pubmed": 32092464, "text": "Skin of atopic dermatitis patients shows disturbed beta-glucocerebrosidase and acid sphingomyelinase activity that relates to changes in stratum corneum lipid composition."}, {"pubmed": 32146630, "text": "Plasma Cytokines Profile in Patients with Parkinson's Disease Associated with Mutations in GBA Gene."}, {"pubmed": 32197197, "text": "Prevalence of GBA p.K198E mutation in Colombian and Hispanic populations."}, {"pubmed": 32220025, "text": "Biofluid Biomarkers in Parkinson's Disease: Clarity Amid Controversy."}, {"pubmed": 32241921, "text": "A common polymorphism in SNCA is associated with accelerated motor decline in GBA-Parkinson's disease."}, {"pubmed": 32303560, "text": "Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson's disease."}, {"pubmed": 32310186, "text": "Age at Onset of Parkinson's Disease Among Ashkenazi Jewish Patients: Contribution of Environmental Factors, LRRK2 p.G2019S and GBA p.N370S Mutations."}, {"pubmed": 32391886, "text": "Glucocerebrosidase deficiency promotes release of alpha-synuclein fibrils from cultured neurons."}, {"pubmed": 32540937, "text": "beta-Glucocerebrosidase activity in GBA-linked Parkinson disease: The type of mutation matters."}, {"pubmed": 32557794, "text": "Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset."}, {"pubmed": 32589593, "text": "Genotype/phenotype relationship in Gaucher disease patients. Novel mutation in glucocerebrosidase gene."}, {"pubmed": 32591474, "text": "GBA variants in REM sleep behavior disorder: A multicenter study."}, {"pubmed": 32620863, "text": "Engineering monocyte/macrophage-specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing."}, {"pubmed": 32623306, "text": "GBA variation and susceptibility to multiple system atrophy."}, {"pubmed": 32641146, "text": "Characterization of a pathogenic variant in GBA for Parkinson's disease with mild cognitive impairment patients."}, {"pubmed": 32677286, "text": "Evaluating the Role of SNCA, LRRK2, and GBA in Chinese Patients With Early-Onset Parkinson's Disease."}, {"pubmed": 32767585, "text": "Penetrance of Glucocerebrosidase (GBA) Mutations in Parkinson's Disease: A Kin Cohort Study."}, {"pubmed": 32767726, "text": "Effects of sphingolipids overload on red blood cell properties in Gaucher disease."}, {"pubmed": 32853481, "text": "GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes."}, {"pubmed": 32879386, "text": "Metabolic alterations in Parkinson's disease astrocytes."}, {"pubmed": 33176831, "text": "The GBA p.G85E mutation in Korean patients with non-neuronopathic Gaucher disease: founder and neuroprotective effects."}, {"pubmed": 33328543, "text": "Validation and assessment of preanalytical factors of a fluorometric in vitro assay for glucocerebrosidase activity in human cerebrospinal fluid."}, {"pubmed": 33388928, "text": "Biochemical markers for severity and risk in GBA and LRRK2 Parkinson's disease."}, {"pubmed": 33443131, "text": "Association of GBA Genotype With Motor and Functional Decline in Patients With Newly Diagnosed Parkinson Disease."}, {"pubmed": 33446243, "text": "Cross-talks among GBA mutations, glucocerebrosidase, and alpha-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review."}, {"pubmed": 33468204, "text": "Fibroblasts from idiopathic Parkinson's disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2."}, {"pubmed": 33483255, "text": "Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes."}, {"pubmed": 33508700, "text": "Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study."}, {"pubmed": 33646158, "text": "The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews."}, {"pubmed": 33665756, "text": "Acid Sphingomyelinase and Acid beta-Glucosidase 1 Exert Opposite Effects on Interleukin-1beta-Induced Interleukin 6 Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes."}, {"pubmed": 33672321, "text": "GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson's Disease."}, {"pubmed": 33711404, "text": "Identification of GBA mutations among neurodegenerative disease patients from eastern India."}, {"pubmed": 33753743, "text": "Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson's disease."}, {"pubmed": 33762134, "text": "The GBA-370Rec Parkinson's disease risk haplotype harbors a potentially pathogenic variant in the mitochondrial gene SLC25A44."}, {"pubmed": 33881531, "text": "Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression."}, {"pubmed": 33998549, "text": "Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers."}, {"pubmed": 34008887, "text": "Intronic Haplotypes in the GBA Gene Do Not Predict Age at Diagnosis of Parkinson's Disease."}, {"pubmed": 34132705, "text": "Bioinformatics analysis and identification of genes and molecular pathways involved in Parkinson's disease in patients with mutations in the glucocerebrosidase gene."}, {"pubmed": 34288055, "text": "Lewy Body-like Inclusions in Human Midbrain Organoids Carrying Glucocerebrosidase and alpha-Synuclein Mutations."}, {"pubmed": 34356092, "text": "Recapture Lysosomal Enzyme Deficiency via Targeted Gene Disruption in the Human Near-Haploid Cell Line HAP1."}, {"pubmed": 34375692, "text": "G325R GBA mutation in Parkinson's disease: Disease course and long-term DBS outcome."}, {"pubmed": 34425330, "text": "Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers."}, {"pubmed": 34583942, "text": "GBA variants influence cognitive status in amyotrophic lateral sclerosis."}, {"pubmed": 34626666, "text": "New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin."}, {"pubmed": 34680941, "text": "Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic GBA Mutation Carriers and Patients with GBA-Associated Parkinson's Disease."}, {"pubmed": 34741486, "text": "Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease."}, {"pubmed": 34930372, "text": "Gaucher disease: clinical phenotypes and refining GBA mutational spectrum in Thai patients."}, {"pubmed": 34984729, "text": "Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers."}, {"pubmed": 34993951, "text": "Children with atopic dermatitis show increased activity of beta-glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieu."}, {"pubmed": 35106798, "text": "GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study."}, {"pubmed": 35332438, "text": "Effect of GBA gene variants on clinical characteristics of dementia with Lewy bodies: a review and meta-analyses."}, {"pubmed": 35362022, "text": "Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote alpha-synuclein aggregation."}, {"pubmed": 35455941, "text": "GBA Variants and Parkinson Disease: Mechanisms and Treatments."}, {"pubmed": 35482760, "text": "Misfolded GBA/beta-glucocerebrosidase impairs ER-quality control by chaperone-mediated autophagy in Parkinson disease."}, {"pubmed": 35604467, "text": "Imaging and genetics in Parkinson's disease: assessment of the GBA1 mutation."}, {"pubmed": 35637196, "text": "GBA1-dependent membrane glucosylceramide reprogramming promotes liver cancer metastasis via activation of the Wnt/beta-catenin signalling pathway."}, {"pubmed": 35779693, "text": "Glucocerebrosidase variant T369M is not a risk factor for Parkinson's disease in Sweden."}, {"pubmed": 35805938, "text": "Seventy-Two-Hour LRRK2 Kinase Activity Inhibition Increases Lysosomal GBA Expression in H4, a Human Neuroglioma Cell Line."}, {"pubmed": 35907343, "text": "Early motor response to dopamine replacement therapy in Parkinson's disease patients carrying GBA variants."}, {"pubmed": 35932311, "text": "Glucocerebrosidase mutations and Parkinson disease."}, {"pubmed": 36130205, "text": "The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines."}, {"pubmed": 36288409, "text": "Dual-phase [18] F-FP-CIT positron emission tomography and cardiac [123] I-MIBG scintigraphy of Parkinson's disease patients with GBA mutations: evidence of the body-first type?"}, {"pubmed": 36565535, "text": "Frequency of non-motor symptoms in Parkinson's disease patients carrying the E326K and T369M GBA risk variants."}, {"pubmed": 36609835, "text": "Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations."}, {"pubmed": 36639889, "text": "Neuronopathic GBA1L444P Mutation Accelerates Glucosylsphingosine Levels and Formation of Hippocampal Alpha-Synuclein Inclusions."}, {"pubmed": 36766684, "text": "Sex-Specific Microglial Responses to Glucocerebrosidase Inhibition: Relevance to GBA1-Linked Parkinson's Disease."}, {"pubmed": 36769009, "text": "DNA Methylation of alpha-Synuclein Intron 1 Is Significantly Decreased in the Frontal Cortex of Parkinson's Individuals with GBA1 Mutations."}, {"pubmed": 36790548, "text": "Impact of GBA variants on longitudinal freezing of gait progression in early Parkinson's disease."}, {"pubmed": 36803808, "text": "Genetic mechanism vs genetic subtypes: The example of GBA."}, {"pubmed": 36828270, "text": "Mechanisms of Glucocerebrosidase Dysfunction in Parkinson's Disease."}, {"pubmed": 36870058, "text": "Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson's disease GBA-N370S dopamine neurons."}, {"pubmed": 37084373, "text": "[Analysis of GBA mutations in patients with Parkinson's disease in the Krasnoyarsk region]."}, {"pubmed": 37116292, "text": "Variants in PSMB9 and FGR differentially affect Parkinson's disease risk in GBA and LRRK2 mutation carriers."}, {"pubmed": 37159513, "text": "CRISPR Correction of the GBA Mutation in Human-Induced Pluripotent Stem Cells Restores Normal Function to Gaucher Macrophages and Increases Their Susceptibility to Mycobacterium tuberculosis."}, {"pubmed": 37280314, "text": "The loss of function GBA1 c.231C > G mutation associated with Parkinson disease."}, {"pubmed": 37563866, "text": "Comparing the effects of GBA variants and onset age on clinical features and progression in Parkinson's disease."}, {"pubmed": 37608502, "text": "Fiber-Specific White Matter Alterations in Parkinson's Disease Patients with GBA Gene Mutations."}, {"pubmed": 37633302, "text": "Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study."}, {"pubmed": 37916476, "text": "Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic Variants."}, {"pubmed": 37921246, "text": "Frequency of Hereditary and GBA1-Related Parkinsonism in Latin America: A Systematic Review and Meta-Analysis."}, {"pubmed": 37926171, "text": "Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study."}, {"pubmed": 38124431, "text": "Clinicogenetic Characterization of Patients with PD and Heterozygous GBA1 Variants in an Indian Cohort."}, {"pubmed": 38203497, "text": "IPSC-Derived Astrocytes Contribute to In Vitro Modeling of Parkinson's Disease Caused by the GBA1 N370S Mutation."}, {"pubmed": 38287861, "text": "The Effect of p.G2019S Mutation in the LRRK2 Gene on the Activity of Lysosomal Hydrolases and the Clinical Features of Parkinson's Disease Associated with p.N370S Mutation in the GBA1 Gene."}, {"pubmed": 38306061, "text": "The Degree of Cardiovascular Autonomic Dysfunction is not Different in GBA-Related and Idiopathic Parkinson's Disease Patients: A Case-Control Instrumental Evaluation."}, {"pubmed": 38390630, "text": "GBA1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians."}, {"pubmed": 38460098, "text": "DJ-1 protects cell death from a mitochondrial oxidative stress due to GBA1 deficiency."}, {"pubmed": 38542193, "text": "Peripheral Upregulation of Parkinson's Disease-Associated Genes Encoding alpha-Synuclein, beta-Glucocerebrosidase, and Ceramide Glucosyltransferase in Major Depression."}, {"pubmed": 38575988, "text": "GBA1 as a risk gene for osteoporosis in the specific populations and its role in the development of Gaucher disease."}, {"pubmed": 38581586, "text": "Altered TFEB subcellular localization in nigral neurons of subjects with incidental, sporadic and GBA-related Lewy body diseases."}], "genomic_pos": [{"chr": "1", "end": 155244699, "ensemblgene": "ENSG00000177628", "start": 155234452, "strand": -1}, {"chr": "HSCHR1_2_CTG31", "end": 49885, "ensemblgene": "ENSG00000262446", "start": 39471, "strand": -1}], "genomic_pos_hg19": [{"chr": "1", "end": 155214490, "start": 155204243, "strand": -1}, {"chr": "HSCHR1_2_CTG31", "end": 155229865, "start": 155219647, "strand": -1}], "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0006680", "qualifier": "involved_in", "term": "glucosylceramide catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006680", "pubmed": [9201993, 16293621, 24211208], "qualifier": "involved_in", "term": "glucosylceramide catabolic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006680", "pubmed": [19279011, 21700325, 24022302, 25584808], "qualifier": "involved_in", "term": "glucosylceramide catabolic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006914", "pubmed": 27378698, "qualifier": "involved_in", "term": "autophagy"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0007005", "pubmed": 25456120, "qualifier": "NOT involved_in", "term": "mitochondrion organization"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0007040", "pubmed": 27378698, "qualifier": "involved_in", "term": "lysosome organization"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0008203", "pubmed": [24211208, 26724485], "qualifier": "involved_in", "term": "cholesterol metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008203", "qualifier": "involved_in", "term": "cholesterol metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008340", "qualifier": "involved_in", "term": "determination of adult lifespan"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009267", "qualifier": "involved_in", "term": "cellular response to starvation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009268", "qualifier": "involved_in", "term": "response to pH"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014004", "qualifier": "involved_in", "term": "microglia differentiation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0016241", "pubmed": 26388395, "qualifier": "involved_in", "term": "regulation of macroautophagy"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0019882", "qualifier": "involved_in", "term": "antigen processing and presentation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0019915", "qualifier": "involved_in", "term": "lipid storage"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021694", "qualifier": "involved_in", "term": "cerebellar Purkinje cell layer formation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021859", "qualifier": "involved_in", "term": "pyramidal neuron differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0022904", "qualifier": "involved_in", "term": "respiratory electron transport chain"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0023021", "pubmed": 19279008, "qualifier": "involved_in", "term": "termination of signal transduction"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0030259", "pubmed": [24211208, 26724485], "qualifier": "involved_in", "term": "lipid glycosylation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0031175", "pubmed": 25456120, "qualifier": "NOT involved_in", "term": "neuron projection development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0031333", "pubmed": 26392287, "qualifier": "involved_in", "term": "negative regulation of protein-containing complex assembly"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032006", "pubmed": 27378698, "qualifier": "involved_in", "term": "regulation of TOR signaling"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032436", "qualifier": "involved_in", "term": "positive regulation of proteasomal ubiquitin-dependent protein catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032715", "pubmed": 19279008, "qualifier": "involved_in", "term": "negative regulation of interleukin-6 production"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0033077", "qualifier": "involved_in", "term": "T cell differentiation in thymus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0033574", "qualifier": "involved_in", "term": "response to testosterone"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0035307", "pubmed": 19279008, "qualifier": "involved_in", "term": "positive regulation of protein dephosphorylation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043161", "qualifier": "involved_in", "term": "proteasome-mediated ubiquitin-dependent protein catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043243", "pubmed": 26392287, "qualifier": "involved_in", "term": "positive regulation of protein-containing complex disassembly"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043407", "pubmed": 19279008, "qualifier": "involved_in", "term": "negative regulation of MAP kinase activity"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043524", "qualifier": "involved_in", "term": "negative regulation of neuron apoptotic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043627", "qualifier": "involved_in", "term": "response to estrogen"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0046512", "pubmed": 19279011, "qualifier": "involved_in", "term": "sphingosine biosynthetic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0046513", "pubmed": 19279011, "qualifier": "involved_in", "term": "ceramide biosynthetic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048469", "qualifier": "involved_in", "term": "cell maturation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048854", "qualifier": "involved_in", "term": "brain morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048872", "qualifier": "involved_in", "term": "homeostasis of number of cells"}, {"evidence": "IC", "gocategory": "BP", "id": "GO:0050728", "pubmed": 19279008, "qualifier": "involved_in", "term": "negative regulation of inflammatory response"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0050905", "qualifier": "involved_in", "term": "neuromuscular process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051402", "qualifier": "involved_in", "term": "neuron apoptotic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0061436", "qualifier": "involved_in", "term": "establishment of skin barrier"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0061518", "qualifier": "involved_in", "term": "microglial cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0061744", "qualifier": "involved_in", "term": "motor behavior"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0071356", "pubmed": 19279008, "qualifier": "involved_in", "term": "cellular response to tumor necrosis factor"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071425", "qualifier": "involved_in", "term": "hematopoietic stem cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071548", "qualifier": "involved_in", "term": "response to dexamethasone"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0072676", "qualifier": "involved_in", "term": "lymphocyte migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0097066", "qualifier": "involved_in", "term": "response to thyroid hormone"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1901805", "qualifier": "involved_in", "term": "beta-glucoside catabolic process"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:1903061", "pubmed": 26392287, "qualifier": "involved_in", "term": "positive regulation of protein lipidation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1904457", "pubmed": 25456120, "qualifier": "involved_in", "term": "positive regulation of neuronal action potential"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1904925", "qualifier": "involved_in", "term": "positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1905037", "qualifier": "involved_in", "term": "autophagosome organization"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:1905165", "pubmed": 25456120, "qualifier": "involved_in", "term": "regulation of lysosomal protein catabolic process"}], "CC": [{"evidence": "IMP", "gocategory": "CC", "id": "GO:0005764", "pubmed": 25202012, "qualifier": "located_in", "term": "lysosome"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0005765", "pubmed": 17897319, "qualifier": "located_in", "term": "lysosomal membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005765", "pubmed": 17187079, "qualifier": "located_in", "term": "lysosomal membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005765", "pubmed": 18022370, "qualifier": "located_in", "term": "lysosomal membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005765", "qualifier": "located_in", "term": "lysosomal membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005783", "qualifier": "located_in", "term": "endoplasmic reticulum"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005794", "qualifier": "located_in", "term": "Golgi apparatus"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005802", "qualifier": "located_in", "term": "trans-Golgi network"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0043202", "pubmed": 18022370, "qualifier": "located_in", "term": "lysosomal lumen"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": 23533145, "qualifier": "located_in", "term": "extracellular exosome"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0004336", "qualifier": "enables", "term": "galactosylceramidase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004348", "qualifier": "enables", "term": "glucosylceramidase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004348", "pubmed": [9201993, 16293621, 19279011, 24211208], "qualifier": "enables", "term": "glucosylceramidase activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0004348", "pubmed": [15916907, 21700325, 23580063, 25584808], "qualifier": "enables", "term": "glucosylceramidase activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0005102", "pubmed": 18022370, "qualifier": "enables", "term": "signaling receptor binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005124", "pubmed": 25202012, "qualifier": "enables", "term": "scavenger receptor binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [21098288, 24162852, 27789271], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0046527", "pubmed": [24211208, 26724485], "qualifier": "enables", "term": "glucosyltransferase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0050295", "pubmed": [24211208, 26724485], "qualifier": "enables", "term": "steryl-beta-glucosidase activity"}]}, "homologene": {"genes": [[5141, 3873626], [6239, 173574], [6239, 177314], [6239, 178535], [6239, 183155], [7955, 559072], [9598, 449571], [9606, 2629], [9615, 612206], [9913, 537087], [10090, 14466], [10116, 684536], [318829, 5048741]], "id": 68040}, "interpro": [{"desc": "Glycoside hydrolase family 30", "id": "IPR001139", "short_desc": "Glyco_hydro_30"}, {"desc": "Glycoside hydrolase superfamily", "id": "IPR017853", "short_desc": "Glycoside_hydrolase_SF"}, {"desc": "Glycosyl hydrolase family 30, beta sandwich domain", "id": "IPR033452", "short_desc": "GH30_C"}, {"desc": "Glycosyl hydrolase family 30, TIM-barrel domain", "id": "IPR033453", "short_desc": "Glyco_hydro_30_TIM-barrel"}], "ipi": ["IPI00021807", "IPI00759616", "IPI00845473", "IPI00940598", "IPI00955453"], "map_location": "1q22", "name": "glucosylceramidase beta 1", "other_names": ["D-glucosyl-N-acylsphingosine glucohydrolase", "SGTase", "acid beta-glucosidase", "alglucerase", "beta-GC", "beta-glucocerebrosidase", "beta-glucosylceramidase 1", "cholesterol glucosyltransferase", "cholesteryl-beta-glucosidase", "glucocerebrosidase", "glucosidase, beta, acid", "glucosylceramidase-like protein", "imiglucerase", "lysosomal acid GCase", "lysosomal acid glucosylceramidase", "lysosomal cholesterol glycosyltransferase", "lysosomal galactosylceramidase", "lysosomal glucocerebrosidase", "lysosomal glycosylceramidase"], "pantherdb": {"HGNC": "4177", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "95665", "ortholog_type": "LDO", "panther_family": "PTHR11069", "taxid": 10090, "uniprot_kb": "P17439"}, {"RGD": "1589149", "ortholog_type": "LDO", "panther_family": "PTHR11069", "taxid": 10116, "uniprot_kb": "B2RYC9"}, {"Ensembl": "ENSGALG00000031002", "ortholog_type": "LDO", "panther_family": "PTHR11069", "taxid": 9031, "uniprot_kb": "A0A3Q2U6X4"}, {"ZFIN": "ZDB-GENE-100922-270", "ortholog_type": "LDO", "panther_family": "PTHR11069", "taxid": 7955, "uniprot_kb": "E7EZM1"}, {"WormBase": "WBGene00016335", "ortholog_type": "O", "panther_family": "PTHR11069", "taxid": 6239, "uniprot_kb": "O16580"}, {"WormBase": "WBGene00008706", "ortholog_type": "O", "panther_family": "PTHR11069", "taxid": 6239, "uniprot_kb": "G5ECR8"}, {"WormBase": "WBGene00016340", "ortholog_type": "O", "panther_family": "PTHR11069", "taxid": 6239, "uniprot_kb": "O16581"}, {"WormBase": "WBGene00021160", "ortholog_type": "LDO", "panther_family": "PTHR11069", "taxid": 6239, "uniprot_kb": "Q9UB00"}, {"FlyBase": "FBgn0051148", "ortholog_type": "O", "panther_family": "PTHR11069", "taxid": 7227, "uniprot_kb": "Q9VCJ4"}, {"FlyBase": "FBgn0051414", "ortholog_type": "LDO", "panther_family": "PTHR11069", "taxid": 7227, "uniprot_kb": "Q8IMY3"}], "uniprot_kb": "P04062"}, "pathway": {"kegg": [{"id": "hsa00511", "name": "Other glycan degradation - Homo sapiens (human)"}, {"id": "hsa00600", "name": "Sphingolipid metabolism - Homo sapiens (human)"}, {"id": "hsa04142", "name": "Lysosome - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1660662", "name": "Glycosphingolipid metabolism"}, {"id": "R-HSA-390466", "name": "Chaperonin-mediated protein folding"}, {"id": "R-HSA-390471", "name": "Association of TriC/CCT with target proteins during biosynthesis"}, {"id": "R-HSA-391251", "name": "Protein folding"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-428157", "name": "Sphingolipid metabolism"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-9840310", "name": "Glycosphingolipid catabolism"}], "smpdb": [{"id": "SMP00034", "name": "Sphingolipid Metabolism"}, {"id": "SMP00347", "name": "Metachromatic Leukodystrophy (MLD)"}, {"id": "SMP00348", "name": "Globoid Cell Leukodystrophy"}, {"id": "SMP00349", "name": "Gaucher Disease"}, {"id": "SMP00525", "name": "Fabry disease"}, {"id": "SMP00526", "name": "Krabbe disease"}], "wikipathways": {"id": "WP1422", "name": "Sphingolipid pathway"}}, "pdb": ["1OGS", "1Y7V", "2F61", "2J25", "2NSX", "2NT0", "2NT1", "2V3D", "2V3E", "2V3F", "2VT0", "2WCG", "2WKL", "2XWD", "2XWE", "3GXD", "3GXF", "3GXI", "3GXM", "3KE0", "3KEH", "3RIK", "3RIL", "5LVX", "6MOZ", "6Q1N", "6Q1P", "6Q6K", "6Q6L", "6Q6N", "6T13", "6TJJ", "6TJK", "6TJQ", "6TN1", "6YTP", "6YTR", "6YUT", "6YV3", "6Z39", "6Z3I", "7NWV", "8AWK", "8AWR", "8AX3", "8P3E", "8P41"], "pfam": ["PF02055", "PF17189"], "pharmgkb": "PA28591", "pharos": {"target_id": 17838, "tdl": "Tclin"}, "pir": ["A94068", "I52980", "I67792"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF249827", "relationship": "is"}, {"id": "GNF249828", "relationship": "is"}, {"id": "GNF249829", "relationship": "is"}, {"id": "GNF249830", "relationship": "is"}], "GNF_hs-Origene": [{"id": "GNF036504", "relationship": "is"}, {"id": "GNF038776", "relationship": "similar to"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF083147", "relationship": "is"}, {"id": "GNF083148", "relationship": "is"}, {"id": "GNF083149", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF052114", "relationship": "is"}, {"id": "GNF056878", "relationship": "is"}, {"id": "GNF061698", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF071393", "relationship": "is"}, {"id": "GNF071394", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF005726", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF235947", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF101868", "relationship": "is"}, {"id": "GNF141523", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_009783.1", "NW_003315906.1"], "protein": ["NP_000148.2", "NP_001005741.1", "NP_001005742.1", "NP_001165282.1", "NP_001165283.1"], "rna": ["NM_000157.4", "NM_001005741.3", "NM_001005742.3", "NM_001005749.1", "NM_001005750.1", "NM_001171811.2", "NM_001171812.2"], "translation": [{"protein": "NP_000148.2", "rna": "NM_000157.4"}, {"protein": "NP_001005742.1", "rna": "NM_001005742.3"}, {"protein": "NP_001165282.1", "rna": "NM_001171811.2"}, {"protein": "NP_001005741.1", "rna": "NM_001005741.3"}, {"protein": "NP_001165283.1", "rna": "NM_001171812.2"}]}, "reporter": {"HG-U133_Plus_2": "209093_s_at", "HG-U95Av2": ["32631_at", "32632_g_at", "40889_at"], "HG-U95B": "43836_s_at", "HTA-2_0": "TC01006304.hg.1", "HuEx-1_0": ["2437205", "2437247"], "HuGene-1_1": "7920697"}, "retired": [79010, 82008, 115185, 115491, 149519, 149533], "summary": "This gene encodes a lysosomal membrane protein that cleaves the beta-glucosidic linkage of glycosylceramide, an intermediate in glycolipid metabolism. Mutations in this gene cause Gaucher disease, a lysosomal storage disease characterized by an accumulation of glucocerebrosides. A related pseudogene is approximately 12 kb downstream of this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2010].", "symbol": "GBA1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414998"}, "unigene": "Hs.282997", "uniprot": {"Swiss-Prot": "P04062", "TrEMBL": ["A0A068F658", "B7Z6S9"]}, "wikipedia": {"url_stub": "Glucocerebrosidase"}}